申请人:Synthelabo
公开号:US04044132A1
公开(公告)日:1977-08-23
The invention provides a new piperazine derivative, 1-(4-fluoro-3-trifluoromethylthio-phenyl)-piperazine of the formula ##STR1## and its pharmaceutically acceptable acid addition salts, which is useful as a medicament in human and veterinary therapy because of its anorexia-inducing effect.
本发明提供了一种新的哌嗪衍生物,即式为##STR1##的1-(4-氟-3-三氟甲基硫基苯基)-哌嗪及其药学上可接受的酸盐衍生物,由于其诱发厌食的作用,在人类和兽医治疗中可用作药物。